Diseases of the cornea of eyeball remain one of the leading causes of vision loss, blindness, and death of the eye. The difficulty and in most cases ineffectiveness of the therapy determines the urgency of the problem of corneal regeneration under the influence of various factors on the corneal.
One of the leading roles in the healing of the cornea is played by its anterior epithelium. In recent years, as a result of studies of regeneration mechanisms and possible ways to control it, relatively new methods of treating inflammatory, dystrophic and ulcerative lesions of this eye structure have appeared, including the use of platelet-rich plasma (PRP) [6, 8]. The possibility of using platelet- and leukocyte-rich plasma (PLRP), representing a newer generation of platelet concentrates, is being studied [9].
